Company / Operating Cash Flow
Bruker Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$134.1M
FY2025
5-year range
$134.1M / $350.1M
FY2021-FY2025
Trend
-46.6%
vs FY2024
Sector context
#95 of 158
Health Care
What the data says
At $134M, Bruker's operating cash flow ranks #95 of 158 in the Health Care sector. Operating Cash Flow has fluctuated over the past 10 years, ranging from $131M in FY2016 to $350M in FY2023.
Based on SEC 10-K filings.
$134M in FY2025 with a 5-year CAGR of -16.6%.
Declined from $350M to $134M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -21.2%
- 5-Year CAGR
- -16.6%
- 10-Year CAGR
- -
Sector benchmark
#95 of 158 in Health CareTop 60% of 158This company $134.1M Sector average $1.0B
▼
-87.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -16.6%, indicating a declining trend.
- In FY2025, operating cash flow decreased 46.6% year-over-year.
- Ranks #95 out of 158 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2023.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $134.1M | -46.6% |
| FY2024 | $251.3M | -28.2% |
| FY2023 | $350.1M | +27.6% |
| FY2022 | $274.4M | -2.8% |
| FY2021 | $282.4M | -15.0% |
| FY2020 | $332.2M | +55.7% |
| FY2019 | $213.4M | -11.0% |
| FY2018 | $239.7M | +55.2% |
| FY2017 | $154.4M | +18.0% |
| FY2016 | $130.8M | -42.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026